Dalhana is immortal by his single monumental work, the commentary on the Susruta Samhita known as Nibandha Samgraha. Nibandha Samgraha compiles views of a large number of authors and commentators and critically analyses them to arrive at a logical conclusion hence the title is quite meaningful. Dalhana was a versatile scholar and as such has contributed in discussing various allied topics which leads to clear understanding of the basic concepts. His outstanding contribution is picturesque interpretation of drugs mentioned in the Susruta Samhita. The commentator belongs to the early medieval period and as such gives valuable information on the cultural condition of his times. The present work is the first of its kind which inaugurates the critical study of the commentaries on the ancient texts of Indian medicine which, apart from being a faithful guide to understand the ancient compendium, presents a rich panorama of cultural data which may be helpful in proper historical understanding.
ABOUT THE AUTHOR P.V. Sharma
Priya Vrat Sharma is well known for his valuable contributions in the field of Ayurveda. During the Last five decades he has written on various aspects of Ayurveda-literary as well as scientific, conceptual as well as historical. Born on 1st November 1920, in a small village near Patna, in the family of traditional vaidyas he gradually acquired highest and held highest posts in academic and administrative fields. In Bihar, he was,for many years. Principal, Govt. Ayurvedic College, Patna and Dy. Director of health Services (I.M.). Finally, he was appointed as Professor of Dravyaguna, also as Head, and later Director of the Postgraduate Institute of Indian Medicine, also dean of the faculty of Indian Medicine in Banaras Hindu University. He retired in 1980. Prof. Sharma has been participating in international conferences abroad and has been associated with several committees on Ayurveda on national level. He has authored about 50 books and has about 500 published papers to his credit.
There are no reviews yet.